Early last week, the Indian government announced that it would reduce export restrictions hydroxychloroquine, a drug that President Trump has been mentioned may potentially help against coronavirus. This is despite the fact that the trials for the controversial medicine is just beginning, and the clinical effectiveness of the security profile, based on evidence of toxicity, and against this virus is still unknown and yet to be determined. President Trump declared that if India did not cooperate in easing measures, then there will be retaliation; accordingly, after Indian Prime Minister Narendra Modi announced the lifting of restrictions, President Trump expressed his gratitude on Twitter:
Extraordinary times require even closer cooperation between friends. Thank you India and the Indian people for the decision on HCQ. Will not be forgotten! Thank you Prime Minister @NarendraModi for your strong leadership in helping not just India, but humanity, in this fight!
— Donald J. Trump (@realDonaldTrump) April 8, 2020
But why Trump Administration had to go to India for this drug? The reality is that India holds the largest share of market production hydroxychloroquine, and produces 70% of world supply. One reason for this is simple-as the drug is the main treatment for malaria, and India have historically malaria prevalence rates are high, there is always a lot of need to produce drugs. However, the Indian pharmaceutical industry is known for much more than just hydroxychloroquine-in fact, the drug is only one among many that contribute to the Indian pharmaceutical industry $ 19 billion. Many commonly used and well-known drugs are widely exported from India, including Paracetamol (also known as Acetaminophen or Tylenol), anti-virals such as acyclovir, vitamins, progesterone, and antimicrobial, among others (these are all listed as part of the export restrictions by the government India).
Indeed, India has always been known for its prolific pharmaceutical industry. This manufacturer of the world’s largest vaccine is home to nearly 3,000 pharmaceutical companies, has a research and development expansive capabilities, promoting the unique rule, has extensive resources for testing and clinical trials, and also has a manufacturing cost almost 33% less than the American States. After extensive market analysis, a renowned global consulting firm PricewaterhouseCoopers (PwC) has unequivocally concluded:”The global players in the pharmaceutical industry can not afford to ignore India. These countries, many predict, will be the most populous in the world by 2050. India will make its mark as a growing market, potential competitors or partners in manufacturing and R & D, and as a location for clinical trials. “
This aspect is always important in foreign policy and trade discussions with India. However, considering the rampant and growing rapidly Coronavirus pandemic, the Indian pharmaceutical skills may play a more important role than usual. In the months and years ahead, clinical trials and research to find a model of therapy and drugs that might be effective against the virus will increase at an exponential rate. This may require a stronger relationship with India, because many drugs, research and development, and a general resource for this therapy is likely to involve the Indian pharmaceutical industry in some form or fashion, given the wide range. As a relevant example of this, Serum Institute of India (SII), in partnership with Codagenix American based company, has announced the development of potential coronavirus vaccines may be eligible and potentially market-ready by 2022. Although this is one of the few companies that working on a vaccine that is worthy of the virus, hope for Indian companies SII high, given the years of expertise in the area: the company is a vaccine manufacturer in the world, and is a leading manufacturer of a lot of regular use and effective vaccines worldwide, including polio, tetanus, diphtheria, and measles, among many others.
If you wish to advertise on Brampton-news, please Contact Us.
The content of this article is not implied to be and should not be relied on or substituted for professional medical advice, diagnosis or treatment by any means, and is not written or intended as such. This content is for information purposes only. Consult with a trained medical professional for medical advice.
